Related Experiment Video
Updated: Jun 27, 2026
High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
Selected Aspects of Ocular Toxicity Studies With a Focus on High-Quality Pathology Reports: A Pathology/Toxicology
1Brian Short Consulting, LLC, Laguna Beach, CA, USA.
Abstract:
Ocular toxicity studies are the bedrock of nonclinical ocular drug and drug-device development, and there has been an evolution in experience, technologies, and challenges to address that ensures safe clinical trials and marketing authorization. The expectations of a well-designed ocular toxicity study and the generation of a coherent, integrative ocular toxicology report and subreports are high, and this article provides a pathology/toxicology consultant's perspective on achieving that goal. The first objective is to cover selected aspects of study designs for ocular toxicity studies including considerations for contract research organization selection, minipig species selection, unilateral versus bilateral dosing, and in-life parameters based on fit-for-purpose study objectives. The main objective is a focus on a high-quality ocular pathology report that includes ocular histology procedures to meet regulatory expectations and a report narrative and tables that correlate microscopic findings with key ophthalmic findings and presents a clear interpretation of test article-, vehicle-, and procedure-related ocular and extraocular findings with identification of adversity and a pathology peer review. The last objective covers considerations for a high-quality ophthalmology report, which in concert with a high-quality pathology report, will pave the way for a best quality toxicology report for an ocular toxicity study.
Insights
This article details best practices for ocular toxicity studies, crucial for drug development. It emphasizes high-quality pathology and ophthalmology reports to ensure drug safety and regulatory approval.
Area of Science:
- Ocular toxicology
- Nonclinical drug development
- Regulatory science
Background:
- Ocular toxicity studies are essential for safe clinical trials and marketing authorization of ocular drugs and drug-device combinations.
- Evolving technologies and challenges necessitate refined study designs and reporting for ocular toxicology.
- High expectations exist for well-designed studies and comprehensive toxicology reports in ocular drug development.
Purpose of the Study:
- To provide a pathology/toxicology consultant's perspective on achieving high-quality ocular toxicity studies.
- To outline key considerations for ocular toxicity study design, including species selection and dosing strategies.
- To emphasize the critical components of a high-quality ocular pathology and ophthalmology report for regulatory submission.
Main Methods:
- Discussion of study design aspects: CRO selection, minipig species choice, unilateral vs. bilateral dosing, and in-life parameters.
- Focus on ocular histology procedures and correlation of microscopic findings with ophthalmic observations.
- Integration of pathology peer review and interpretation of test article-related findings for adversity identification.
Main Results:
- Guidelines for selecting appropriate study designs tailored to specific objectives.
- Methodologies for generating comprehensive ocular pathology reports that meet regulatory standards.
- Strategies for creating integrated toxicology reports by combining pathology and ophthalmology findings.
Conclusions:
- A well-designed ocular toxicity study, supported by high-quality pathology and ophthalmology reports, is vital for regulatory success.
- Adherence to best practices in study design and reporting ensures the generation of robust safety data for ocular products.
- This consultant's perspective offers a roadmap for optimizing ocular toxicology assessments in nonclinical development.
Related Concept Videos
01:26Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:23Toxicity Testing in Animals